| Literature DB >> 33445454 |
Johanna Simon1,2, Gabor Kuhn1,2, Michael Fichter3, Stephan Gehring3, Katharina Landfester1, Volker Mailänder1,2.
Abstract
Understanding the behavior of nanoparticles upon contact with a physiological environment is of urgent need in order to improve their properties for a successful therapeutic application. Most commonly, the interaction of nanoparticles with plasma proteins are studied under in vitro conditions. However, this has been shown to not reflect the complex situation after in vivo administration. Therefore, here we focused on the investigation of magnetic nanoparticles with blood proteins under in vivo conditions. Importantly, we observed a radically different proteome in vivo in comparison to the in vitro situation underlining the significance of in vivo protein corona studies. Next to this, we found that the in vivo corona profile does not significantly change over time. To mimic the in vivo situation, we established an approach, which we termed "ex vivo" as it uses whole blood freshly prepared from an animal. Overall, we present a comprehensive analysis focusing on the interaction between nanoparticles and blood proteins under in vivo conditions and how to mimic this situation with our ex vivo approach. This knowledge is needed to characterize the true biological identity of nanoparticles.Entities:
Keywords: biodistribution; in vivo; nanoparticle; plasma; protein corona; serum
Year: 2021 PMID: 33445454 PMCID: PMC7826990 DOI: 10.3390/cells10010132
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600